Literature DB >> 18684414

Priorities for diabetes primary care in Europe.

Van Eygen Luk1, Sunaert Patricia, Feyen Luc, Borgermans Liesbeth, De Maeseneer Jan.   

Abstract

The European Forum for Primary Care (EFPC) held a consultation process among European experts and identified the elements considered to be essential for high quality diabetes care. More attention should go to diabetes prevention. An interdisciplinary team should provide comprehensive shared care, focused on patient empowerment. The further development of ICT is important to facilitate communication and quality monitoring. The EFPC argues the case for a primary care-centred approach to ensure equity and cost-effectiveness. But this is only possible with a strong primary care infrastructure. In many European countries important investments are needed to strengthen primary care.

Entities:  

Mesh:

Year:  2008        PMID: 18684414     DOI: 10.1016/j.pcd.2007.11.001

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  2 in total

1.  Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study.

Authors:  Salwa S Zghebi; Mamas A Mamas; Darren M Ashcroft; Chris Salisbury; Christian D Mallen; Carolyn A Chew-Graham; David Reeves; Harm Van Marwijk; Nadeem Qureshi; Stephen Weng; Tim Holt; Iain Buchan; Niels Peek; Sally Giles; Martin K Rutter; Evangelos Kontopantelis
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

2.  Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.

Authors:  Salwa S Zghebi; Martin K Rutter; Darren M Ashcroft; Chris Salisbury; Christian Mallen; Carolyn A Chew-Graham; David Reeves; Harm van Marwijk; Nadeem Qureshi; Stephen Weng; Niels Peek; Claire Planner; Magdalena Nowakowska; Mamas Mamas; Evangelos Kontopantelis
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.